MedTrace Logo

Methods Study to Characterize Early Indicators of Weight Loss in People

NCT00383253 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2009-03-23

No results posted yet for this study

Summary

Methods study to characterize early indicators of weight loss in people.

Conditions

Interventions

BEHAVIORAL

caloric restriction - 10%

Subjects maintained on 10% caloric restriction (caloric intake = 90% of baseline)

BEHAVIORAL

caloric restriction - 25%

Subjects maintained on 25% caloric restriction (caloric intake = 75% of baseline)

BEHAVIORAL

caloric restriction - 50%

Subjects maintained on 50% caloric restriction (caloric intake = 50% of baseline)

BEHAVIORAL

caloric restriction - Control

Subjects maintained on their baseline caloric intake (caloric restriction = none)

Sponsors & Collaborators

  • University of Adelaide

    collaborator OTHER

  • Royal Adelaide Hospital

    collaborator OTHER

  • Pfizer

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Completion
2008-03-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00383253 on ClinicalTrials.gov